Science
AI structure prediction speeds discovery of 'molecular glues' to treat disease
Publication: Phys.org - latest science and technology news stories
Author: Not available in collected metadata
Source published: 29/09/2026, 20:30:01 UTC
Briefing created: 29/09/2026, 20:40:49 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 29/09/2026, 20:40:24 UTC.
Briefings
A Baylor College of Medicine-led team published in Nature Communications developed an AI strategy combining protein analysis to discover 'molecular glues' for blood cancers and autoimmune diseases. The research demonstrates how AI structural modeling optimizes compounds before experimental validation, accelerating the treatment of harmful proteins linked to these conditions.
Key points
- A Baylor College of Medicine-led team published a strategy in Nature Communications using AI to analyze thousands of proteins for discovering molecular glues.
- The AI approach optimizes compounds before experiments reveal their function, potentially neutralizing proteins linked to blood cancers and autoimmune diseases.
Context and limitations
Evidence covers only the AI strategy and initial findings; specific compound structures, experimental validation results, and long-term clinical trial data remain unreported.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 29/09/2026, 20:40:49 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeidqjaionldchdrgdrc5umreudrerrttc65nl4wkz74h45nqy76wea